首页> 美国卫生研究院文献>BioMed Research International >Helical Irradiation of the Total Skin with Dose Painting to Replace Total Skin Electron Beam Therapy for Therapy-Refractory Cutaneous CD4+ T-Cell Lymphoma
【2h】

Helical Irradiation of the Total Skin with Dose Painting to Replace Total Skin Electron Beam Therapy for Therapy-Refractory Cutaneous CD4+ T-Cell Lymphoma

机译:螺旋线照射全身皮肤并用剂量绘画代替难治性皮肤性CD4 + T细胞淋巴瘤的整体皮肤电子束治疗

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

A 36-year-old woman was diagnosed with a therapy-refractory cutaneous CD4+ T-cell lymphoma, T3N0M0B0, and stage IIB. Helical irradiation of the total skin (HITS) and dose painting techniques, with 30 Gy in 40 fractions interrupted at 20 fractions with one week resting, 4 times per week were prescribed. The diving suit was dressed whole body to increase the superficial dose and using central core complete block (CCCB) technique for reducing the internal organ dose. The mean doses of critical organs of head, chest, and abdomen were 2.1 to 29.9 Gy, 2.9 to 8.1 Gy, and 3.6 to 15.7 Gy, respectively. The mean dose of lesions was 84.0 cGy. The dosage of left side pretreated area was decreased 57%. The tumor regressed progressively without further noduloplaques. During the HITS procedure, most toxicity was grade I except leukocytopenia with grade 3. No epitheliolysis, phlyctenules, tumor lysis syndrome, fever, vomiting, dyspnea, edema of the extremities, or diarrhea occurred during the treatment. HITS with dose painting techniques provides precise dosage delivery with impressive results, sparing critical organs, and offering limited transient and chronic sequelae for previously locally irradiated, therapy-refractory cutaneous T-cell lymphoma.
机译:一名36岁的妇女被诊断患有难治性皮肤CD4 + T细胞淋巴瘤,T3N0M0B0和IIB期。规定对全部皮肤进行螺旋线照射(HITS)和剂量涂装技术,按40个部分的30 Gy剂量,在20个部分时中断,休息1周,每周4次。潜水服全身穿着以增加表层剂量,并使用中央核心完全封闭(CCCB)技术减少内部器官剂量。头部,胸部和腹部的关键器官的平均剂量分别为2.1至29.9 Gy,2.9至8.1 Gy和3.6至15.7 Gy。病变的平均剂量为84.0 cGy。左侧预处理区域的剂量减少了57%。肿瘤逐渐消退,无其他结节。在HITS程序中,除白细胞减少症为3级外,大多数毒性为I级。在治疗过程中未发生上皮细胞溶解,小囊泡,肿瘤溶解综合征,发烧,呕吐,呼吸困难,四肢浮肿或腹泻。采用剂量涂装技术的HITS可提供精确的剂量递送,并具有令人印象深刻的结果,节省关键器官,并为先前局部照射,治疗难治性皮肤T细胞淋巴瘤提供有限的短暂和慢性后遗症。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号